Literature DB >> 16253633

Elevated glucose activates protein synthesis in cultured cardiac myocytes.

Wen Yeshao1, Jiali Gu, Xianghong Peng, Angus C Nairn, Jerry L Nadler.   

Abstract

Diabetes mellitus results in chronic hyperglycemia, a serious metabolic disorder associated with a markedly increased risk of cardiovascular disease. However, the effects of high glucose (HG) on cardiac myocyte growth have not been fully clarified. In this study, the effect of glucose on cardiac myocyte growth was examined using leucine incorporation as an index of protein synthesis. High glucose (HG, 25 mmol/L) increased leucine incorporation (167% +/- 0.2% over normal glucose, n=4, P<.01) compared with a physiological glucose concentration (5.5 mmol/L, normal glucose). The HG-induced increase in leucine incorporation was time- and dose-dependent and was not due to osmotic changes because 25 mmol/L mannitol did not change leucine incorporation. High glucose also significantly reduced elongation factor 2 phosphorylation, an effect known to result in increased protein synthesis at the elongation step. Western blot analysis showed that HG-activated protein kinase B (PKB), also called Akt (PKB/Akt), at 18 hours. High glucose-induced leucine incorporation was attenuated with phosphatidylinositol 3-kinase (PI3K) inhibition using wortmannin and LY294002 and by rapamycin, a mammalian target of rapamycin (mTOR) inhibitor, 72%, 64%, and 65% (P<.05), respectively. High glucose also activated extracellular signal-regulated kinase 1/2 activity with peak stimulation at 5 minutes. In addition, PD98059, an inhibitor of mitogen-activated protein kinase kinase, attenuated HG-induced leucine incorporation. These data show for the first time that elevated glucose increases protein synthesis in cardiac myocytes. The increase appears to be mediated by activation of PI3K-PKB/Akt and/or PI3K-mTOR as well as extracellular signal-regulated kinase 1/2. These results provide new evidence for a direct effect of glucose independent of insulin on cardiac myocyte growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253633     DOI: 10.1016/j.metabol.2005.05.010

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Regulation of IRSp53-dependent filopodial dynamics by antagonism between 14-3-3 binding and SH3-mediated localization.

Authors:  Jeffrey M Robens; Lee Yeow-Fong; Elsa Ng; Christine Hall; Ed Manser
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

2.  Regulation of hepatic energy metabolism and gluconeogenesis by BAD.

Authors:  Alfredo Giménez-Cassina; Luisa Garcia-Haro; Cheol Soo Choi; Mayowa A Osundiji; Elizabeth A Lane; Hu Huang; Muhammed A Yildirim; Benjamin Szlyk; Jill K Fisher; Klaudia Polak; Elaura Patton; Jessica Wiwczar; Marina Godes; Dae Ho Lee; Kirsten Robertson; Sheene Kim; Ameya Kulkarni; Alberto Distefano; Varman Samuel; Gary Cline; Young-Bum Kim; Gerald I Shulman; Nika N Danial
Journal:  Cell Metab       Date:  2014-02-04       Impact factor: 27.287

Review 3.  The Peroxisome Proliferator-Activated Receptor-Gamma Coactivator-1α-Heme Oxygenase 1 Axis, a Powerful Antioxidative Pathway with Potential to Attenuate Diabetic Cardiomyopathy.

Authors:  Maayan Waldman; Michael Arad; Nader G Abraham; Edith Hochhauser
Journal:  Antioxid Redox Signal       Date:  2020-03-25       Impact factor: 8.401

4.  PUFAs supplementation affects the renal expression of pannexin 1 and connexins in diabetic kidney of rats.

Authors:  Martina Luetić; Marija Vitlov Uljević; Tomislav Mašek; Benjamin Benzon; Katarina Vukojević; Natalija Filipović
Journal:  Histochem Cell Biol       Date:  2019-12-20       Impact factor: 4.304

5.  Portal glucose delivery stimulates muscle but not liver protein metabolism.

Authors:  Guillaume Kraft; Katie C Coate; Dominique Dardevet; Ben Farmer; E Patrick Donahue; Phillip E Williams; Alan D Cherrington; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-25       Impact factor: 4.310

Review 6.  Unbreak my heart: targeting mitochondrial autophagy in diabetic cardiomyopathy.

Authors:  Dieter A Kubli; Åsa B Gustafsson
Journal:  Antioxid Redox Signal       Date:  2015-04-28       Impact factor: 8.401

7.  Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.

Authors:  Karina Huynh; Julie R McMullen; Tracey L Julius; Joon Win Tan; Jane E Love; Nelly Cemerlang; Helen Kiriazis; Xiao-Jun Du; Rebecca H Ritchie
Journal:  Diabetes       Date:  2010-03-09       Impact factor: 9.461

Review 8.  Heat shock proteins in diabetes and wound healing.

Authors:  Mustafa Atalay; Niku Oksala; Jani Lappalainen; David E Laaksonen; Chandan K Sen; Sashwati Roy
Journal:  Curr Protein Pept Sci       Date:  2009-02       Impact factor: 3.272

9.  Glucose regulates protein turnover and growth-related mechanisms in rainbow trout myogenic precursor cells.

Authors:  M N Latimer; R M Reid; P R Biga; B M Cleveland
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2019-03-21       Impact factor: 2.888

10.  Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning.

Authors:  Tamás Baranyai; Csilla Terézia Nagy; Gábor Koncsos; Zsófia Onódi; Melinda Károlyi-Szabó; András Makkos; Zoltán V Varga; Péter Ferdinandy; Zoltán Giricz
Journal:  Cardiovasc Diabetol       Date:  2015-11-18       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.